risks of glp-1 drugs Medications: Everything You Need to Know TrimRX | Why GLP-1 Medications
Description
doi: 10.1007/s12012-024-09884-z
Novo Nordisks share price rose by more than 4% on Monday on news of the launch, but is still down by 44% over the past year amid fierce competition from US rival Eli Lillys jabs Mounjaro and Zepbound
The question has gained visibility due to anecdotal accounts of so-called Ozempic babies. This paper aims to delineate mechanisms linking GLP-1 receptor activation with reproductive outcomes, review clinical data on fertility, and outline implications for practice
The Florida Department of Health did not respond to requests for comment on this story
Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG
Exenatide reduces urinary transforming growth factor-beta1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria
